GLP-1 Weight Loss Medications in North Carolina

North Carolina expanded Medicaid in December 2023, extending coverage to approximately 600,000 additional adults. This was a transformative event for healthcare access across the state. For GLP-1 medications, expansion means newly eligible adults with type 2 diabetes can access covered GLP-1 therapy. Weight management coverage under NC Medicaid is still being defined, but the expansion significantly broadens the population with potential GLP-1 access.

North Carolina benefits from the Research Triangle area (Raleigh-Durham-Chapel Hill), which houses three major academic medical centers: Duke, UNC, and WakeMed. These institutions offer both in-person and telehealth weight management services. The Charlotte metro, anchored by Atrium Health, provides another hub. For rural eastern and western NC, telehealth is critical — several counties are designated Health Professional Shortage Areas with limited specialist access.

Blue Cross Blue Shield of North Carolina dominates the commercial market, covering approximately 4 million residents. BCBS NC has been expanding its formulary to include anti-obesity medications for qualifying patients. Prior authorization typically requires documented BMI >= 30 (or >= 27 with comorbidities), failed lifestyle interventions, and sometimes step therapy through other weight management approaches.

Unlike many states, North Carolina requires nurse practitioners to maintain a collaborative practice agreement with a supervisory physician. This affects telehealth platforms that rely heavily on NPs for prescribing. While NPs can still prescribe GLP-1s, they must have physician oversight, which can affect appointment availability. Physician-led telehealth services may be more straightforward in NC.